期刊文献+

大疱性类天疱疮患者临床特征和系统损害与性别的相关性 被引量:2

The Correlation among Gender,Clinical Characteristics and Systemic Damage of Bullous Pemphigoid
下载PDF
导出
摘要 目的评价BP系统损害与性别的相关性。方法回顾性分析113例BP患者的临床表现、实验室指标和治疗方法。结果 BP患者临床表现与性别不相关(P>0.05);但女性患者血红蛋白量降低的发生率和尿液中白细胞数明显高于男性,男性患者的血尿水平及治疗前后血ALT,BUN和GGT升高的水平均明显高于女性患者(P均<0.05)。另外,有肝肾损害者治疗时激素起始用量较无肝肾损害者高,住院时间也较后者长,两者差异均有统计学意义(P均<0.001)。结论 BP患者肝肾损害在性别上存在差异,有或无肝肾损害影响患者的治疗和预后,应早期针对肝肾损害情况制定治疗方案,以减少疾病复发。 Objective To compare the clinical characteristics of bullous pemphigoid (BP) in male and female patients correlation between gender and systemic damage of BP. Methods A retrospective analysis was performed on clinical figures, laboratory findings, treatment and the prognosis of the 113 BP patients. Results There was no significant difference between gender in clinical manifestations of BP( P 〉 0.05 ). In female patients The incidence of lower hemoglobin and urine WBC count in were significantly higher than in male. The level of hematuria and the elevated level of blood ALT, BUN, and GGT before and after treatment in male were significantly higher than that in female(P 〈 0.05 both). In addition, whether have liver and kidney damage or not, the starting dose of corticosteroid therapy and the time in hospital have significant difference ( P 〈 0.001 both). Conclusion The differences between gender in liver and kidney damage of BP, which im- pacted the treatment and prognosis is distinct and should be pay attention to, especially in male. The further formulate treatment program should be taken to reduce the recurrence of the disease.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2011年第7期542-543,546,共3页 The Chinese Journal of Dermatovenereology
关键词 类天疱疮 大疱性 男性 女性 临床特点 相关性 Pemphigoid Bullous Male Female Clinical characteristics Correlation
  • 相关文献

参考文献8

  • 1张学军.皮肤性病学[M].6版.北京:人民出版社,2006:107-108
  • 2赵克中,刘洪旗,刘建峰,韩瑞红.大疱性类天疱疮肾损害一例[J].中华肾脏病杂志,2007,23(9):620-620. 被引量:1
  • 3Wojnarowska F, Kirtschig G, ftighet AS, et al. Guidelines for the management of bullous pemphigoid[ J]. British Journal of Dermatology, 2002, 147(2) : 214 -221.
  • 4Stefania L,Hakan MG, Ahmed AR. Serological studies in Bullous Pem- phigoid : a literature review of antibody titers at presentation and in clini- cal remission[J]. Acta Derm Venereo1,2010,90(2) : 115 - 121.
  • 5Bernard P, Reguiai Z,Tancrede-Bohin E. Risk factors for relapse in patients with bullous pemphigoid in clinical remission [ J ]. Arch Dermatol, 2009, 145(5) : 537 -542.
  • 6Enno S, Karin O, Eva-Bettina B, et al. Serum levels of autoantibodies to BPI80 correlate with disease activity in patients with Bullous Pemphi- goid[J]. Arch Dermatol, 2000, 136(2) : 174- 178.
  • 7李妍,王娣,陈喜雪,钟珊,邱于芳,赵俊郁,朱学骏.BP180NC16a与大疱性类天疱疮病情变化的关系[J].中国皮肤性病学杂志,2009,23(6):332-334. 被引量:8
  • 8王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:30

二级参考文献18

  • 1朱学骏,李冠群.大疱性类天疱疮111例治疗经验总结[J].临床皮肤科杂志,1996,25(4):213-216. 被引量:13
  • 2王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:30
  • 3KOBAYASHI M, AMAGAI M, KURODA-KINOSHITA K, et al. BP180 ELISA using bacterial recombinant NCI6a protein as a diagnostic and monitoring tool for bullous pemphigoid [ J ]. J Dermatol Sci, 2002, 30(3) :224 -232.
  • 4TSUJI-ABE Y, AKIYAMA M, YAMANAKA Y, et al. Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 measured using BP180 ELISA kit in bullous pemphigoid[ J]. J Dermatol Sci, 2005, 37(3) :145 - 149.
  • 5MATSUMURA K, AMAGAI M, NISHIKAWA T, et al. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen [J]. Arch Dermatol Res, 1996,288(9) :507 -509.
  • 6ZILLIKENS D, MASCARO J M, ROSE P A, et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti- BP180 autoantibodies in patients with bullous pemphigoid [ J ]. J Invest Dermatol, 1997, 109 (5) :679 - 683.
  • 7SAKUMA-OYAMA Y, POWELL A M, OYAMA N, et al. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid [ J ]. Br J Dermatol, 2004,151 ( 1 ) : 126 -131.
  • 8SCHMIDT E, OBE K, CKER E B, et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid [ J ]. Arch Dermatol, 2000,136 (2) : 174 - 178.
  • 9FENG S, WU Q, JIN P, et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid [J]. Int J Dermatol, 2008,47 (3) :225 - 228.
  • 10Wojnarowska F,Kirtschig G,Highet AS,et al.Guidelines for the management of bullous pemphigoid.Br J Dermatol,2002,147 (2):214-221.

共引文献70

同被引文献22

  • 1王娣,陈喜雪,朱学骏.124例大疱性类天疱疮治疗回顾[J].中华皮肤科杂志,2007,40(1):7-9. 被引量:30
  • 2Kasperkiewicz M, Zillikens D. The pathophysiology of bullous pemphigoid[ J]. Clin Rev Allergy Immunol, 2007,33 (1-2) :67- 77.
  • 3Kirtschig G, Khumalo NP. Management of Bullous Pemphigoid : recommendations for immunomodulatory treatments [ J ]. Am J Clin Dermatol, 2004,5 (5) : 319-326.
  • 4徐牧迟.外用糖皮质激素软膏与联合系统使用中等剂量糖皮质激素治疗大疱性类天疱疮的研究[C].2011全国中西医结合皮肤性病学术会议论文集,2011-04-14,13-14.
  • 5Boughrara Z, Ingen-Housz-Oro S, Legrand P, et al. Cutaneous infections in bullous pemphigoid patients treated with topical corti- costeroids] [ J]. Ann Dermatol Venereol, 2010, 137 (5) : 345- 351.
  • 6Joly P, Roujeau JC, Benichou J, et al. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid [ J ]. N Engl J Med, 2002,346(5 ) :321-327.
  • 7Murrell DF, Daniel BS, Joly P, et al. Definitions and outcome measures for bullous pemphigoid : recommendations by an interna- tional panel of experts[ J]. J Am Acad Dennatol, 2012,66(3 ) : 479-485.
  • 8Westerhof W. Treatment of bullous pemphigoid with topical clobe- tasol propionate [ J ]. JAmAead Dermatol, 1989,20 (3) : 458- 461.
  • 9Du-Thanh A, Merlet S, Maillard H, et al. Combined treatment with low-dose methotrexate and initial short-term superpotent topi- cal steroids in bullous pemphigoid: an open, multicentre, retro- spective study [ J ]. Br J Dermatol, 2011,165 (6) : 1337-1343.
  • 10Ahluwalia A. Topical glucoeorticoids and the skin mechanisms of action : an update[ J ]. Mediators Inflamm, 1998,7 ( 3 ) : 183- 193.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部